338-OR: Regulation of Pancreatic Beta-Cell Survival and Function During Aging

Jimin Park,Menghao Huang,Jingru Liang,X. Charlie Dong
DOI: https://doi.org/10.2337/db24-338-or
IF: 7.7
2024-01-01
Diabetes
Abstract:Introduction & Objective: Type 2 diabetes is often associated with pancreatic beta cell impairment or failure. However, it is poorly understood how beta cells are adapted or maladapted to both intrinsic and extrinsic stresses during aging. The objective of this work is to investigate the role of SIRT6, an NAD-dependent deacetylase, in the regulation of beta cells during aging. Methods: Both gain-of-function and loss-of-function approaches were used to illustrate the function of SIRT6 in the regulation of beta cell survival and function in cell and animal models. Glucose tolerance and insulin secretion analyses were performed to assess the underlying pathophysiology. Immunofluorescence microscopy was performed to illustrate cell survival or death. RNA-seq analysis was performed to profile transcriptomic changes. Results: We performed glucose tolerance tests in beta cell-specific Sirt6 knockout and transgenic mice at young and old ages. Our results show a strong beneficial effect of Sirt6 on systemic glucose tolerance in the transgenic mice and deteriorated glucose tolerance in the knockout mice compared to wild-type mice of young and old ages. Our RNA-seq and imaging data reveal a key role of Sirt6 in the protection against beta cell senescence and death. Among numerous potential target genes of Sirt6, we evaluated RRAD and GEM like GTPase 2 (REM2, an endogenous inhibitor of high-voltage-activated calcium channels) as a key downstream player. Indeed, knockdown or knockout of Rem2 in beta cells significantly improve Sirt6 deficiency-induced cellular senescence and death. Additionally, beta cell-specific Rem2 knockout mice exhibit improved glucose tolerance. Conclusion: This study demonstrates that SIRT6 is a critical regulator of beta cell survival and function during aging. Boosting SIRT6 levels and/or activities could be a strategy for maintaining healthy beta cells into the late ages. J. Park: None. M. Huang: None. J. Liang: None. X. Dong: None. National Institute on Aging (R21AG072288)
What problem does this paper attempt to address?